Cargando…

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis

INTRODUCTION: On-treatment HCV RNA measurements are crucial for the prediction of a sustained virological response (SVR) and to determine treatment futility during protease inhibitor-based triple therapies. In patients with advanced liver disease an accurate risk/benefit calculation based on reliabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maasoumy, Benjamin, Hunyady, Bela, Calvaruso, Vincenza, Makara, Mihály, Vermehren, Johannes, Haragh, Attila, Susser, Simone, Bremer, Birgit, Cloherty, Gavin, Manns, Michael P., Craxì, Antonio, Wedemeyer, Heiner, Sarrazin, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229112/ https://www.ncbi.nlm.nih.gov/pubmed/25389779 http://dx.doi.org/10.1371/journal.pone.0110857

Ejemplares similares

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
por: Mücke, Marcus M., et al.
Publicado: (2019)

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
por: Hunyady, Béla, et al.
Publicado: (2018)

Epidemiology of HCV infection in the Central European region
por: Urbánek, Petr, et al.
Publicado: (2016)

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response
por: Cloherty, Gavin, et al.
Publicado: (2016)

Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
por: Griemsmann, Marie, et al.
Publicado: (2022)

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
por: Maasoumy, Benjamin, et al.
Publicado: (2017)

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
por: Tergast, Tammo L., et al.
Publicado: (2023)

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
por: Dietz, Julia, et al.
Publicado: (2016)

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program
por: Calvaruso, Vincenza, et al.
Publicado: (2019)

Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience
por: Sandmann, Lisa, et al.
Publicado: (2021)

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms
por: Vermehren, Johannes, et al.
Publicado: (2017)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
por: Meyer, Manuela F, et al.
Publicado: (2007)

Dual Function of the NK Cell Receptor 2B4 (CD244) in the Regulation of HCV-Specific CD8+ T Cells
por: Schlaphoff, Verena, et al.
Publicado: (2011)

New therapeutic options for HCV in Central Europe
por: Flisiak, Robert, et al.
Publicado: (2016)

IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort
por: Pár, Alajos, et al.
Publicado: (2014)

Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
por: Maasoumy, Benjamin, et al.
Publicado: (2022)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany
por: Hillert, Annika, et al.
Publicado: (2021)

Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
por: Aliabadi, Elmira, et al.
Publicado: (2022)

Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023)

PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C
por: Markova, Antoaneta A., et al.
Publicado: (2014)

Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
por: Wiesmann, F., et al.
Publicado: (2015)

Heart rate variability is associated with disease severity and portal hypertension in cirrhosis
por: Miceli, Giuseppe, et al.
Publicado: (2023)

Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
por: Wedemeyer, Heiner, et al.
Publicado: (2020)

Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors
por: Wiesmann, F., et al.
Publicado: (2014)

Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy
por: Schulte, Benjamin, et al.
Publicado: (2020)

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
por: Van, Nguyen Dinh, et al.
Publicado: (2016)

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis
por: Kimmann, Markus, et al.
Publicado: (2019)

Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites
por: Tergast, Tammo L., et al.
Publicado: (2018)

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
por: Maasoumy, Benjamin, et al.
Publicado: (2013)

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance
por: Calvaruso, Vincenza, et al.
Publicado: (2013)

Breakthroughs in hepatitis C research: from discovery to cure
por: Manns, Michael P., et al.
Publicado: (2022)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites
por: Schultalbers, Marie, et al.
Publicado: (2020)

Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2020)

Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
por: Bhardwaj, Suvercha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oe3al5n7etlsjm9bkiqtdl8357